SESSION TITLE: Preconditions and Outcomes in Lung Transplantation
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Lung transplantation is an emerging therapeutic option for end-stage lung disease. While steroids are not absolutely contraindicated for lung transplantation candidates, previous guideline recommended to maintain prednisolone lower than 20mg if possible. However, since 2006, the recommended dose for steroids was disappeared from guidelines due to many controversial study results. Because, the cessation of steroids is not feasible in many patients with end-stage lung disease, the present study aimed to compare clinical outcomes of Lung transplantation patients according to their steroids use.